Treatment of pediatric hypertension

Pharmacotherapy

Volumn 20, Issue 2, 2000, Pages 140-150

  Temple, Mary E ^a   Nahata, Milap C ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLOROTHIAZIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENALAPRILAT; ESMOLOL; FELODIPINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; ISRADIPINE; LABETALOL; METOLAZONE; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PROPRANOLOL; SPIRONOLACTONE;

ADOLESCENT; BLOOD PRESSURE REGULATION; DRUG EFFICACY; DRUG SAFETY; DRUG SELECTIVITY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTENSION; MALE; REVIEW; VASODILATATION;

EID: 0033964750     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.3.140.34782     Document Type: Review

References (69)

1. National Heart, Lung, and Blood Institute. Update on the 1987 cask force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure education program. Pediatrics 1996;98:649-58.
2. Lieberman E. Pediatric hypertension: clinical perspective. Mayo Clin Proc 1994;69:1098-1107.
3. Sinaiko A. Hypertension in children. N Engl J Med 1996;335:1968-73.
4. Goble MM. Hypertension in infancy. Pediatr Clin North Am 1993;40:105-23.
5. Sinaiko A. Pharmacologic management of childhood hypertension. Pediatr Clin North Am 1993;40:195-212.
6. Hohn AR, Dwyer KM, Dwyer JH. Blood pressure in youth from four ethnic groups: the Pasadena project. J Pediatr 1994;125:368-73.
7. Alpert BS, Fox ME. Racial aspects of blood pressure in children and adolescents. Pediatr Clin North Am 1993;40:13-22.
8. Rosner B, Prineas R, Loggie J, Daniels S. Percentile for body mass index in U.S. children 5 to 17 years of age. J Pediatr 1998;132:211-22.
9. Sinaiko A, Donahue R, Jacobs DR, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin and lipids in young adults. Circulation 1999;99:1471-6.
10. Gutin B, Basch C, Shea S, et al. Blood pressure, fitness, and fatness in 5 and 6 year old children. JAMA 1990;264:1123-7.
11. Rocchini AP, Katch V, Anderson J, et al. Blood pressure in obese adolescents: effect of weight loss. Pediatrics 1988;82:16-23.
12. Kaplan TW, Spence MA. Genetics of essential hypertension. Am J Med 1993;94:77-82.
13. Zinner SH, Rosner B, Oh W, Kass EH. Significance of blood pressure in infancy: familial aggregation and predictive effect on later blood pressure. Hypertension 1985;7:411-16.
14. Londe S, Bourgoignie JJ, Robson AM, Goldring D. Hypertension in apparently normal children. J Pediatr 1971;78:569-77.
15. Munger RG, Prineas RJ, Gomez-Marin O. Persistent elevation of blood pressure among children with a history of hypertension: the Minneapolis children's blood pressure study. J Hypertens 1988;6:647-53.
16. Miller K. Pharmacologic management of hypertension in pediatric patients. Drugs 1994;48:868-87.
17. Hohn AR. Diagnosis and management of hypertension in childhood. Pediatr Ann 1997;26:105-10.
18. Rocchini AP. Cardiovascular causes of systemic hypertension. Pediatr Clin North Am 1993;40:141-55.
19. American Academy of Pediatrics Recommendations for preventive pediatric health care (RE 9535). Pediatrics 1995;96:1-6.
20. Gomez-Marian O, Prineas RJ, Rastam L Cuff bladder width and measurement in children and adolescents. J Hypertens 1992;10:1235-41.
21. Sadowski RH, Falkner B. Hypertension in pediatric patients. Am J Kidney Dis 1996;27:305-15.
22. Task Force for Blood Pressure Control in Children. Report of the second task force on blood pressure control in children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987;79:1-25.
23. Rocchini AP, Key J, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure in obese adolescents. N Engl J Med 1989;321:580-5.
24. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. N Engl J Med 1992;327:1350-5.
25. Sinaiko AR, Gomez-Marin O, Prineas RJ. Effect of low sodium diet or potassium supplementation on adolescent blood pressure. Hypertension 1993;21:989-94.
26. Jung FF, Ingelfinger JR. Hypertension in childhood and adolescence. Pediatr Rev 1993;14:169-79.
27. Sinaiko AR. Clinical pharmacology of converting enzyme inhibitors, calcium channel blockers and diuretics. J Hum Hypertens 1994;8:389-94.
28. Resnick L. Calcium metabolism, renin activity, and the antihypertensive effects of calcium channel blockade. Am J Med 1986;81:6-14.
29. Kasian GF, Ninan A, Duncan WJ, et al. Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia. Can J Cardiol 1988:4:181-4.
30. Khattak S, Rogan JW, Saunders EF, Theis JG, Arbus GS, Koren G. Efficacy of amlodipine in pediatric bone marrow transplant patients. Clin Pediatr 1998;37:31-6
31. Tallian KB, Nahata MC, Turman MA, Mahan JD, Hayes JR, Menster MI. Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol 1999;13:304-10.
32. Johnson CE, Jacobson PA, Song MH. Isradipine therapy in hypertensive pediatric patients. Ann Pharmacother 1997;31:704-7.
33. Larson A, Tobias JD. Nicardipine for the treatment of hypertension following cardiac transplantation in a 14-year-old boy. Clin Pediatr 1994;25:309-11.
34. Siegler RL, Brewer ED. Effect of sublingual or oral nifedipine in the treatment of hypertension. J Pediatr 1988;5:811-13.
35. Hosie J, Bremner DA, Fell PJ. Comparison of early side effects with amlodipine and nifedipine in hypertension. Cardiology 1992;80:S4-9.
36. Singh BN, Josephson MA. Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine. Am Heart J 1990;119:427-34.
37. Futraku N, Pochanugool C, Sitprija V, et al. Renal dysfunction in glomerulonephropathy associated with rapid onset renal failure. Renal Failure 1997;19:77-84.
38. Rocha-Goncalves F, Moura B, Periera-Migual JM, Mariano-Pego G. Isradipine in the treatment of mild to moderate hypertension in geriatric patients. Am J Hypertens 1994;7:S64-6.
39. Endresen L, Bergan S, Holdaas H, Pran T, Sinding-Larsen B, Berg KJ. Lack of effect of the calcium channel antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients. Ther Drug Monit 1991;13:490-5.
40. MacDonald JL, Johnson CE, Jacobson P Stability of isradipine in an extemporaneously compounded oral liquid. Am J Hosp Pharm 1994;51:2409-11.
41. Mirkin BL, Newman TJ. Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the international collaborative group. Pediatrics 1985;75:1091-2002.
42. Bouissou F, Meguire B, Rostin M, Fontaine C, Charlet JP, Barthe PH. Long term therapy by captopril in children with renal hypertension. Clin Exp Theory Pract 1986;8:841-5.
43. Callis L, Vila A, Catala J, Gras X. Long term treatment with captopril in pediatric patients with severe hypertension and chronic renal failure. Clin Exp Theory Pract 1986;8:847-51.
44. Sinaiko AR, Mirkin BL, Hendrick DA, Green TP, O'Dea RF. Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease. Pediatrics 1983;103:799-810.
45. Miller K, Atkin B, Rodel PV, Walker JF Enalapril: a well tolerated and efficacious agent for the pediatric hypertensive patient. J Cardiovasc Pharmacol 1987;10:S154-6.
46. Tack ED, Perlman JM Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 1988;112:805-10.
47. Schneeweiss A. Cardiovascular drugs in children. Angiotensin converting enzyme inhibitors in pediatric patients. Pediatr Cardiol 1990;11:199-207.
48. Sinaiko A. Kashtan CE, Mirkin BL. Antihypertensive drug therapy with captopril in children and adolescents. Clin Exp Theory Pract 1986;8:829-39.
49. Kornbluth A, Frishman WH, Ackerman M β-Adrenergic blockade in children. Cardiol Clin 1987;5:629-49.
50. Griswold WR, McNeal R, Mendoza SA. Propranolol as an antihypertensive agent in children. Arch Dis Child 1978;53:594-8.
51. Boertl RC. Effect of propranolol in the treatment of hypertension in children. Pediatr Res 1976;10:328-32.
52. Falkner B, Lowenthal DT, Affrime MB. The pharmacodynamic effectiveness of metoprolol in adolescent hypertension. Pediatr Pharmacol 1982;2:49-52.
53. Ishisaka DY, Yonan CD, Housel BF. Labetolol treatment of hypertension in a child. Clin Pharm 1991;10:500-1.
54. Fivush B, Neu A, Furth S. Acute hypertensive crises in children: emergencies and urgencies. Curr Opin Pediatr 1997;9:233-6.
55. Deal JE, Barratt TM, Dillon MJ. Management of hypertensive emergencies. Arch Dis Child 1992;67:1089-92.
56. Reisman L, Reid S. Management of systemic hypertension in children. Pediatr Ann 1982;11:604-14.
57. Thien TA, Huysmans FT, Gerlag PG, Koene RA, Wijdevand PG. Diazoxide infusion in severe hypertension and hypertensive crises. Clin Pharmacol Ther 1979;25:795-9.
58. Gruskin AB, Dabbagh S, Fleischmann LE, Atiyeh BA. Application since 1980 of antihypertensive agents to treat pediatric disease. J Hum Hypertens 1994;8:381-8.
59. Bunchman TE, Lynch R, Wood EG Intravenously administered labetolol for treatment of hypertension in children. J Pediatr 1992;120:140-4.
60. Michael J, Groshong T, Tobias JD. Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 1998;12:40-2.
61. Treluyer JM, Hubert P, Jouvet P. Intravenous nicardipine in hypertensive children. Eur J Pediatr 1993;152:712-14.
62. Tobias JD. Nicardipine to control mean arterial pressure in a pediatric intensive care population. Am J Anesthesiol 1996;23:109-12.
63. Tobias JD, Lowe S, Deshpande JK. Nicardipine: perioperative applications in children. Pediatr Anesth 1995;5:171-6.
64. Groshong T. Hypertensive crises in children. Pediatr Ann 1996;25:368-76.
65. Evans JHC, Shaw NJ, Brocklebank JT. Sublingual nifedipine in acute severe hypertension. Arch Dis Child 1988;63:975-7.
66. Dilmen U, Caglar K, Senses A, Kinik E. Nifedipine in hypertensive emergencies in children. Am J Dis Child 1983;137:1162-5.
67. Lopez-Herce J, Albajara L, Garcia S, Ruza F. Treatment of hypertensive crises in children with nifedipine. Intensive Care Med 1988;14:519-21.
68. Roth B, Herkenrath J, Krebber J, Abu-Chaaban T. Nifedipine in hypertensive crises in infants and children. Clin Exp Theory Pract 1986;A8:871-7.
69. Abdelwahab W, Frishman W, Landau A. Management of hypertensive urgencies and emergencies. J Clin Pharmacol 1995;35:747-62.